Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
Boyages
J
J
Department of Radiation Oncology, Westmead Hospital, New South Wales, Australia.
Tiver
K W
KW
D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy / Q000379:methods / Q000592:standards; D008593:Menopause; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010052:Ovariectomy / Q000592:standards; D011878:Radiotherapy; D016032:Randomized Controlled Trials as Topic; D011960:Receptors, Estrogen; D015996:Survival Rate; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000277:Adjuvants, Pharmaceutic; D011960:Receptors, Estrogen; D013629:Tamoxifen